{"id":"W2163188114","doi":"10.1093/annonc/mdl165","title":"Phase I study of Aplidine in a daily×5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115","year":2006,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Microbial Natural Products and Biosynthesis","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"ca_institutions":"Northeast Cancer Centre; Université de Montréal; Hôpital Notre-Dame; Children's Hospital of Eastern Ontario; Ottawa Hospital; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Rash; Nausea; Adverse effect; Vomiting; myalgia; Mucositis; Internal medicine; Phases of clinical research; Progressive disease; Gastroenterology; Toxicity; Lung cancer; Surgery; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006299642,0.001109433,0.001194187,0.0004621881,0.0004256033,0.0007353724,0.0009249317,0.001142299,0.004445025],"category_scores_gemma":[0.0005555787,0.0005033318,0.0009119748,0.0004328753,0.0007753086,0.0005654104,0.0002543193,0.002774036,0.0009069109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007732839,"about_ca_system_score_gemma":0.001468667,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003475183,"about_ca_topic_score_gemma":0.006306695,"domain_scores_codex":[0.9998498,0.00006345038,0.000005493438,0.00002741668,0.00001492848,0.00003898611],"domain_scores_gemma":[0.9995982,0.00006706895,0.00006629352,0.00002985443,0.00002141315,0.0002172317],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7283245,0.06734209,0.00305783,0.001142082,0.001257618,0.0003215726,0.0003341187,0.003577382,0.03200601,0.000719072,0.01316981,0.148748],"study_design_scores_gemma":[0.6502341,0.3355157,0.007443748,0.00004723853,0.0002123871,0.0002085821,0.00007363494,0.001122552,0.001665332,0.000227168,0.003217224,0.00003229062],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9853314,0.003924636,0.000742955,0.0009279249,0.0003041217,0.002277495,0.001825501,0.0002480496,0.004417875],"genre_scores_gemma":[0.9836103,0.003834884,0.001690102,0.001204735,0.0001793045,0.002164924,0.002331629,0.00004699848,0.004937175],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004445025,"threshold_uncertainty_score":0.01487005,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1319914723872837,"score_gpt":0.4477888923124596,"score_spread":0.3157974199251758,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}